Gene · 5607
Papers1,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mechanism Based on Histopathology, Antioxidant System and Transcriptomic Profiles in Heat Stress Response in the Gills of Japanese Flounder. | Int J Mol Sci | 2022 | 35328705 | PubTator, text mining | PubMed |
| Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer. | Cells | 2022 | 35326402 | PubTator, text mining | PubMed |
| Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype. | Mol Carcinog | 2022 | 35319795 | PubTator, text mining | PubMed |
| Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation. | ESC Heart Fail | 2022 | 35315235 | PubTator, text mining | PubMed |
| The Role of IL-17-Mediated Inflammatory Processes in the Pathogenesis of Intervertebral Disc Degeneration and Herniation: A Comprehensive Review. | Front Cell Dev Biol | 2022 | 35309927 | PubTator, text mining | PubMed |
| Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys. | Front Endocrinol (Lausanne) | 2022 | 35295987 | PubTator, text mining | PubMed |
| Associations between Gene-Gene Interaction and Overweight/Obesity of 12-Month-Old Chinese Infants. | Biomed Res Int | 2022 | 35295960 | PubTator, text mining | PubMed |
| Impact of deleterious missense PRKCI variants on structural and functional dynamics of protein. | Sci Rep | 2022 | 35260606 | PubTator, text mining | PubMed |
| Genetic susceptibility to hereditary non-medullary thyroid cancer. | Hered Cancer Clin Pract | 2022 | 35255942 | PubTator, text mining | PubMed |
| Breadth and Specificity in Pleiotropic Protein Kinase A Activity and Environmental Responses. | Front Cell Dev Biol | 2022 | 35252178 | PubTator, text mining | PubMed |
| Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation. | Pharm Biol | 2022 | 35244521 | PubTator, text mining | PubMed |
| Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling. | Int J Mol Sci | 2022 | 35216134 | PubTator, text mining | PubMed |
| Cytokine Receptors-Regulators of Antimycobacterial Immune Response. | Int J Mol Sci | 2022 | 35163035 | PubTator, text mining | PubMed |
| Obese Patients Experience More Severe CSA than Non-Obese Patients. | Int J Environ Res Public Health | 2022 | 35162313 | PubTator, text mining | PubMed |
| miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention. | Sci Rep | 2022 | 35149732 | PubTator, text mining | PubMed |
| Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review). | Exp Ther Med | 2022 | 35069866 | PubTator, text mining | PubMed |
| Clinical Significance and Regulation of ERK5 Expression and Function in Cancer. | Cancers (Basel) | 2022 | 35053510 | PubTator, text mining | PubMed |
| Pharmacological Effects of Grifolin: Focusing on Anticancer Mechanisms. | Molecules | 2022 | 35011516 | PubTator, text mining | PubMed |
| Arecoline induces cardiotoxicity by upregulating and activating cardiac hypertrophy-related pathways in Sprague-Dawley rats. | Chem Biol Interact | 2022 | 34999050 | PubTator, text mining | PubMed |
| Hesperidin delays cell cycle progression into the G0/G1 phase via suspension of MAPK signaling pathway in intrahepatic cholangiocarcinoma. | J Biochem Mol Toxicol | 2022 | 34984768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5607/papers?page=14